Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09UVK
|
|||
| Drug Name |
MK-8835A
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 3 | [1] | |
| Company |
Merck Kenilworth, NJ, Pfizer New York, NY
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.